Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study

INTRODUCTION: The efficacy and safety of switching to insulin glargine 300 U/mL (Gla-300) in type 2 diabetes mellitus (T2DM) uncontrolled on basal insulin (BI) has been demonstrated in the North American and Western European populations; however, there is limited data from other geographical regions...

Descripción completa

Detalles Bibliográficos
Autores principales: Sethi, Bipin, Al-Rubeaan, Khalid, Unubol, Mustafa, Mabunay, Maria A., Berthou, Baptiste, Pilorget, Valerie, Vethakkan, Shireene R., Frechtel, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205141/
https://www.ncbi.nlm.nih.gov/pubmed/35713873
http://dx.doi.org/10.1007/s13300-022-01271-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205141/
https://www.ncbi.nlm.nih.gov/pubmed/35713873
http://dx.doi.org/10.1007/s13300-022-01271-7

Ejemplares similares